None of the 11 search results reference "SPCC320.03 Antibody" or variants of this nomenclature.
The provided materials focus on antibodies targeting proteins such as CD3 , CD352 , SPCS3 , Caspase-3 , 14-3-3 proteins , SEB , Claudin-3 , IRF3 , Histone H3.3 G34R , and DPEP3 .
Possible explanations for the absence of data:
Typographical error in the compound name (e.g., "SPCS3" or "SC-003" may be similar but distinct entities).
Proprietary or obscure designation not yet published in peer-reviewed literature.
Target specificity outside the scope of the provided sources (e.g., oncology, immunology, or infectious diseases).
To resolve this discrepancy, consider the following steps:
Verify the compound name with the original source (e.g., manufacturer, research publication).
Expand the search scope to include proprietary databases (e.g., CAS Registry, PubMed Central, clinical trial registries).
Consult recent literature (post-2025) for emerging antibody therapeutics or research tools.
For reference, below are summaries of analogous antibody research from the provided sources:
KEGG: spo:SPCC320.03
STRING: 4896.SPCC320.03.1
SPCC320.03 is a protein encoded by the SPCC320.03 gene in Schizosaccharomyces pombe (fission yeast). Antibodies targeting this protein are valuable tools for investigating protein localization, expression levels, and functional interactions in cellular contexts. Similar to other S. pombe protein-specific antibodies, SPCC320.03 antibodies enable researchers to track protein dynamics during cell division, stress responses, and other cellular processes. These antibodies are particularly significant for exploring conserved cellular mechanisms, as many S. pombe proteins have functional homologs in higher eukaryotes, including humans .
Rigorous validation is essential before using SPCC320.03 antibodies in your research. Recommended validation techniques include:
Western blotting against wild-type and knockout/knockdown strains to confirm band specificity
Immunoprecipitation followed by mass spectrometry to verify target binding
Immunofluorescence microscopy comparing wild-type and deletion strains
Using recombinant SPCC320.03 protein as a positive control
When performing Western blots, run samples under both reducing and non-reducing conditions to understand how disulfide bonds might affect epitope accessibility. For immunofluorescence experiments, include appropriate controls such as secondary antibody-only samples to detect non-specific binding .
For optimal preservation of antibody activity:
Store concentrated antibody stocks at -80°C in small aliquots to avoid repeated freeze-thaw cycles
Working dilutions can be stored at 4°C with 0.02% sodium azide as a preservative for up to one month
When thawing frozen aliquots, allow them to equilibrate to room temperature gradually
Avoid vortexing antibodies; instead, mix by gentle inversion or flicking
Monitor antibody performance regularly using positive controls
If antibody activity decreases over time, consider performing a buffer exchange to remove potential degradation products that may interfere with binding efficiency .
A typical immunoprecipitation protocol for S. pombe proteins using SPCC320.03 antibody includes:
Prepare spheroplasts from S. pombe cultures using Zymolyase or equivalent enzymes
Lyse cells in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, and protease inhibitor cocktail
Pre-clear lysates with Protein A/G beads
Incubate clarified lysates with SPCC320.03 antibody (2-5 μg per 1 mg protein) overnight at 4°C
Add Protein A/G beads and incubate for 2-3 hours
Wash beads extensively with lysis buffer
Elute bound proteins using SDS sample buffer or gentle elution conditions if native protein is needed
Analyze by SDS-PAGE followed by Western blotting or mass spectrometry
The choice between native and denaturing conditions depends on whether you aim to preserve protein-protein interactions .
Epitope mapping for SPCC320.03 antibody can be approached using several complementary methods:
Peptide array analysis: Synthesize overlapping peptides (15-20 amino acids) spanning the SPCC320.03 sequence and test antibody binding
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Compare exchange rates in free protein versus antibody-bound protein
Site-directed mutagenesis: Create point mutations in recombinant SPCC320.03 and assess changes in antibody binding
X-ray crystallography or cryo-EM: Determine the structure of the antibody-antigen complex at atomic resolution
For peptide array analysis, incorporate a sliding window approach where each peptide overlaps with adjacent peptides by 5-10 amino acids. This helps ensure that conformational epitopes spanning multiple segments are not missed. The epitope information can guide the design of experiments with mutant proteins and enhance interpretation of functional studies .
When faced with cross-reactivity challenges:
Antibody purification: Perform antigen-specific affinity purification similar to techniques described for GST-fusion peptide antibodies
Pre-absorption: Incubate antibody with lysates from SPCC320.03 deletion strains to remove cross-reactive antibodies
Epitope competition assays: Include excess purified antigen or specific peptides to block specific binding
Alternative detection methods: Complement antibody-based detection with mass spectrometry or genetically tagged versions of SPCC320.03
Increased stringency in washing steps: Optimize detergent concentration and salt conditions
For complex samples, consider a dual-recognition approach using two antibodies targeting different epitopes on SPCC320.03, which dramatically reduces false positives .
Advanced protein-protein interaction studies with SPCC320.03 antibody can include:
Co-immunoprecipitation followed by mass spectrometry: Identify interaction partners under various cellular conditions
Proximity labeling: Combine with BioID or APEX2 systems to identify proximal proteins in living cells
ChIP-seq applications: If SPCC320.03 is a chromatin-associated protein, map genomic binding sites
PLA (Proximity Ligation Assay): Visualize interactions with candidate proteins in situ
FRET analysis: When combined with fluorescently tagged candidate partners
For co-immunoprecipitation experiments, crosslinking with formaldehyde (0.1-1%) can help preserve transient interactions. Compare interaction profiles under different growth conditions or cell cycle stages to identify context-dependent binding partners .
For precise quantification of SPCC320.03:
Quantitative Western blotting: Use standard curves with recombinant protein
ELISA development: Design sandwich ELISA with capture and detection antibodies
Flow cytometry: For single-cell quantification if working with permeabilized cells
Mass spectrometry with isotope-labeled peptides: Combine with immunoprecipitation for absolute quantification
Image-based cytometry: Quantify immunofluorescence signals in large cell populations
When developing quantification methods, validate dynamic range and linearity using samples with known concentrations of target protein. For Western blot quantification, housekeeping proteins like β-actin serve as loading controls, though their expression may vary under certain conditions .
To minimize background in immunofluorescence microscopy:
Blocking optimization: Test different blocking agents (BSA, normal serum, casein) at various concentrations
Fixation method comparison: Compare methanol, paraformaldehyde, and glutaraldehyde fixation effects on background
Antibody titration: Test serial dilutions to find optimal signal-to-noise ratio
Pre-absorption protocols: Incubate antibody with acetone powder from knockout strains
Detergent adjustment: Optimize concentration and type of detergents in washing buffers
For S. pombe cells, spheroplasting conditions significantly impact antibody accessibility to intracellular antigens. Optimize digestion time with cell wall-degrading enzymes to balance structural preservation with antibody penetration .
Key factors influencing Western blot sensitivity include:
Sample preparation: Protease inhibitor selection, denaturing conditions, and protein extraction efficiency
Gel percentage: Optimize based on protein size (higher percentage for smaller proteins)
Transfer conditions: Buffer composition, membrane type (PVDF vs. nitrocellulose), and transfer time/voltage
Blocking parameters: Type of blocking agent, concentration, and duration
Antibody concentration: Optimal dilution determination through titration
Detection system: Enhanced chemiluminescence (ECL) vs. fluorescent detection methods
When working with low abundance proteins, consider using signal enhancement systems or loading higher amounts of protein (up to 75-100 μg per lane). For membrane proteins, addition of SDS (0.1%) to antibody dilution buffer can improve accessibility of epitopes .
For effective proteinase K protection assays:
Prepare spheroplasts from log-phase S. pombe cultures
Resuspend in appropriate buffer (typically 50 mM Tris-HCl pH 7.5, 250 mM sucrose, 5 mM MgCl₂)
Divide samples for different treatments: intact organelles, detergent-solubilized, and various proteinase K concentrations
Incubate with proteinase K (10-100 μg/ml) for 15-30 minutes on ice
Stop digestion with PMSF (final concentration 1-2 mM)
Analyze by SDS-PAGE and Western blotting with SPCC320.03 antibody
This assay helps determine protein topology and membrane association. Protected fragments detected by the antibody can provide insights into domain organization and membrane orientation .
For successful ChIP experiments:
Crosslinking optimization: Test formaldehyde concentrations (0.5-3%) and incubation times (5-20 minutes)
Sonication conditions: Determine optimal cycles and intensity to generate 200-500 bp fragments
Antibody amount: Typically 2-5 μg per ChIP reaction, but this requires optimization
Controls: Include IgG control, input sample, and positive control regions
Sequential ChIP: For co-occupancy studies with other proteins
Analysis methods: qPCR for candidate regions or sequencing for genome-wide profiling
When designing ChIP-qPCR primers, target multiple regions around suspected binding sites and include negative control regions. For S. pombe, prepare at least 10⁷-10⁸ cells per ChIP reaction to ensure sufficient material .
To evaluate effects of post-translational modifications:
Phosphatase treatment: Compare antibody recognition before and after phosphatase treatment
Site-directed mutagenesis: Mutate potential modification sites (S/T/Y for phosphorylation) to non-modifiable residues
Modified peptide competition: Use peptides with specific modifications to compete for antibody binding
2D gel electrophoresis: Separate proteins by both pI and molecular weight to resolve modified forms
Mass spectrometry: Identify specific modifications present in immunoprecipitated protein
For proteins with multiple potential modification sites, combine these approaches to build a comprehensive understanding of how modifications impact antibody recognition and function .
For cell cycle dynamics studies:
Synchronization approaches: Compare results from different methods (nitrogen starvation, hydroxyurea block, temperature-sensitive cdc mutants)
Time-course sampling: Collect samples at regular intervals after synchronization
Co-staining: Combine with cell cycle markers (Cdc13, Sid2) or DNA staining
Quantitative image analysis: Measure fluorescence intensity, localization changes, and morphological parameters
Live-cell imaging: If using SPCC320.03 antibody fragments or complementary tagged constructs
When analyzing S. pombe cell cycle data, note that cultures typically lose synchrony after 1-2 divisions. For extended experiments, consider using multiple synchronization points or microfluidic devices for continuous imaging .
When facing contradictory results:
Epitope accessibility analysis: Different sample preparation methods may expose or mask epitopes
Protocol comparison: Systematically compare fixation methods, buffers, and detection systems
Antibody batch testing: Verify consistency between antibody lots
Complementary approaches: Use genetically tagged versions of SPCC320.03 or mass spectrometry
Controls re-evaluation: Review positive and negative controls for each technique
Create a detailed troubleshooting matrix comparing all experimental variables across contradictory experiments. Often, discrepancies arise from subtle differences in experimental conditions rather than actual biological variability .
For robust statistical analysis:
Normalization methods: Choose appropriate housekeeping genes or total protein normalization
Replicate design: Minimum of three biological replicates with technical duplicates
Statistical tests: t-tests for simple comparisons, ANOVA for multiple conditions
Power analysis: Determine sample size needed for desired statistical power
Outlier identification: Apply consistent criteria for identifying and handling outliers
Effect size reporting: Include confidence intervals and effect sizes, not just p-values
When reporting antibody-based quantification, always include details about normalization methods, antibody dilution, exposure times, and image processing parameters to ensure reproducibility .
For quantitative co-localization analysis:
Pearson's correlation coefficient: Measures linear correlation between fluorescence intensities
Manders' overlap coefficient: Quantifies fraction of pixels with co-localization
Intensity correlation analysis: Determines whether intensities vary together
Object-based methods: Count co-localized objects rather than pixels
3D co-localization: Extend analysis to three dimensions for volumetric imaging